量子分子共振和显微解剖术对腰椎病治疗作用的确认性研究(前瞻性队列,随访 6 个月)。

IF 1.5 Q4 CLINICAL NEUROLOGY
Scandinavian Journal of Pain Pub Date : 2024-03-06 eCollection Date: 2024-01-01 DOI:10.1515/sjpain-2023-0077
Ángeles Canós-Verdecho, Ruth Robledo, Rosa Izquierdo, Ara Bermejo, Elisa Gallach, David Abejón, Pilar Argente, Isabel Peraita-Costa, María Morales-Suárez-Varela
{"title":"量子分子共振和显微解剖术对腰椎病治疗作用的确认性研究(前瞻性队列,随访 6 个月)。","authors":"Ángeles Canós-Verdecho, Ruth Robledo, Rosa Izquierdo, Ara Bermejo, Elisa Gallach, David Abejón, Pilar Argente, Isabel Peraita-Costa, María Morales-Suárez-Varela","doi":"10.1515/sjpain-2023-0077","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Low back pain is a common musculoskeletal complaint and while prognosis is usually favorable, some patients experience persistent pain despite conservative treatment and invasive treatment to target the root cause of the pain may be necessary. The aim of this study is to evaluate patient outcomes after treatment of lumbar radiculopathy (LR) with quantum molecular resonance radiofrequency coblation disc decompression and percutaneous microdiscectomy with grasper forceps (QMRG).</p><p><strong>Methods: </strong>This prospective cohort study was carried out in two Spanish hospitals on 58 patients with LR secondary to a contained hydrated lumbar disc hernia or lumbar disc protrusion of more than 6 months of evolution, which persisted despite conservative treatment with analgesia, rehabilitation, and physiotherapy, and/or epidural block, in the previous 2 years. Patients were treated with QMRG and the outcomes were measured mainly using the Douleur Neuropathique en 4 Questions, Numeric Rating Scale, Oswestry Disability Index, SF12: Short Form 12 Health Survey, Patient Global Impression of Improvement, Clinical Global Impression of Improvement, and Medical Outcomes Study Sleep Scale.</p><p><strong>Results: </strong>Patients who received QMRG showed significant improvement in their baseline scores at 6 months post-treatment. The minimal clinically important difference (MCID) threshold was met by 26-98% of patients, depending on the outcome measure, for non-sleep-related outcomes, and between 17 and 62% for sleep-related outcome measures. Of the 14 outcome measures studied, at least 50% of the patients met the MCID threshold in 8 of them.</p><p><strong>Conclusion: </strong>Treatment of LR with QMRG appears to be effective at 6 months post-intervention.</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Confirmatory study of the usefulness of quantum molecular resonance and microdissectomy for the treatment of lumbar radiculopathy in a prospective cohort at 6 months follow-up.\",\"authors\":\"Ángeles Canós-Verdecho, Ruth Robledo, Rosa Izquierdo, Ara Bermejo, Elisa Gallach, David Abejón, Pilar Argente, Isabel Peraita-Costa, María Morales-Suárez-Varela\",\"doi\":\"10.1515/sjpain-2023-0077\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Low back pain is a common musculoskeletal complaint and while prognosis is usually favorable, some patients experience persistent pain despite conservative treatment and invasive treatment to target the root cause of the pain may be necessary. The aim of this study is to evaluate patient outcomes after treatment of lumbar radiculopathy (LR) with quantum molecular resonance radiofrequency coblation disc decompression and percutaneous microdiscectomy with grasper forceps (QMRG).</p><p><strong>Methods: </strong>This prospective cohort study was carried out in two Spanish hospitals on 58 patients with LR secondary to a contained hydrated lumbar disc hernia or lumbar disc protrusion of more than 6 months of evolution, which persisted despite conservative treatment with analgesia, rehabilitation, and physiotherapy, and/or epidural block, in the previous 2 years. Patients were treated with QMRG and the outcomes were measured mainly using the Douleur Neuropathique en 4 Questions, Numeric Rating Scale, Oswestry Disability Index, SF12: Short Form 12 Health Survey, Patient Global Impression of Improvement, Clinical Global Impression of Improvement, and Medical Outcomes Study Sleep Scale.</p><p><strong>Results: </strong>Patients who received QMRG showed significant improvement in their baseline scores at 6 months post-treatment. The minimal clinically important difference (MCID) threshold was met by 26-98% of patients, depending on the outcome measure, for non-sleep-related outcomes, and between 17 and 62% for sleep-related outcome measures. Of the 14 outcome measures studied, at least 50% of the patients met the MCID threshold in 8 of them.</p><p><strong>Conclusion: </strong>Treatment of LR with QMRG appears to be effective at 6 months post-intervention.</p>\",\"PeriodicalId\":47407,\"journal\":{\"name\":\"Scandinavian Journal of Pain\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-03-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Pain\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/sjpain-2023-0077\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/sjpain-2023-0077","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:腰痛是一种常见的肌肉骨骼疾病,虽然预后通常良好,但有些患者在接受保守治疗后仍会出现持续性疼痛,因此可能需要针对疼痛根源进行侵入性治疗。本研究旨在评估量子分子共振射频钴化椎间盘减压术和带抓钳的经皮显微椎间盘切除术(QMRG)治疗腰椎病(LR)后的患者预后:这项前瞻性队列研究是在两家西班牙医院进行的,对象是 58 名因腰椎间盘水肿疝或腰椎间盘突出而继发的腰椎间盘突出症患者,病程超过 6 个月,尽管在过去两年中接受了镇痛、康复、理疗和/或硬膜外阻滞等保守治疗,但病情仍持续存在。患者接受了 QMRG 治疗,治疗结果主要通过四项问题神经病变评分量表、数字评分量表、Oswestry 残疾指数、SF12:简表 12 健康调查、患者总体改善印象、临床总体改善印象和医疗结果研究睡眠量表进行测量:结果:接受 QMRG 治疗的患者在治疗后 6 个月的基线评分有明显改善。对于非睡眠相关结果,26%-98%的患者达到了最小临床重要差异(MCID)阈值,具体取决于结果测量指标;对于睡眠相关结果,17%-62%的患者达到了最小临床重要差异(MCID)阈值。在研究的 14 项结果指标中,至少有 50%的患者在其中 8 项达到了 MCID 临界值:结论:在干预后 6 个月,使用 QMRG 治疗 LR 似乎是有效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Confirmatory study of the usefulness of quantum molecular resonance and microdissectomy for the treatment of lumbar radiculopathy in a prospective cohort at 6 months follow-up.

Objectives: Low back pain is a common musculoskeletal complaint and while prognosis is usually favorable, some patients experience persistent pain despite conservative treatment and invasive treatment to target the root cause of the pain may be necessary. The aim of this study is to evaluate patient outcomes after treatment of lumbar radiculopathy (LR) with quantum molecular resonance radiofrequency coblation disc decompression and percutaneous microdiscectomy with grasper forceps (QMRG).

Methods: This prospective cohort study was carried out in two Spanish hospitals on 58 patients with LR secondary to a contained hydrated lumbar disc hernia or lumbar disc protrusion of more than 6 months of evolution, which persisted despite conservative treatment with analgesia, rehabilitation, and physiotherapy, and/or epidural block, in the previous 2 years. Patients were treated with QMRG and the outcomes were measured mainly using the Douleur Neuropathique en 4 Questions, Numeric Rating Scale, Oswestry Disability Index, SF12: Short Form 12 Health Survey, Patient Global Impression of Improvement, Clinical Global Impression of Improvement, and Medical Outcomes Study Sleep Scale.

Results: Patients who received QMRG showed significant improvement in their baseline scores at 6 months post-treatment. The minimal clinically important difference (MCID) threshold was met by 26-98% of patients, depending on the outcome measure, for non-sleep-related outcomes, and between 17 and 62% for sleep-related outcome measures. Of the 14 outcome measures studied, at least 50% of the patients met the MCID threshold in 8 of them.

Conclusion: Treatment of LR with QMRG appears to be effective at 6 months post-intervention.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Scandinavian Journal of Pain
Scandinavian Journal of Pain CLINICAL NEUROLOGY-
CiteScore
3.30
自引率
6.20%
发文量
73
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信